This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2009 May;11(3):163-4.

doi: 10.1007/s11912-009-0024-4.

Circulating tumor cells in metastatic castration-resistant prostate cancer

Affiliations

PMID: 19336007
DOI: 10.1007/s11912-009-0024-4

Comment

Circulating tumor cells in metastatic castration-resistant prostate cancer

Brian I Rini. Curr Oncol Rep. 2009 May.

. 2009 May;11(3):163-4.

doi: 10.1007/s11912-009-0024-4.

Author

Affiliation

¹ Cleveland Clinic Taussig Cancer Institute, Cleveland, OH 44195, USA. rinib2@ccf.org

PMID: 19336007
DOI: 10.1007/s11912-009-0024-4

No abstract available

PubMed Disclaimer

Comment on

Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer.
de Bono JS, Scher HI, Montgomery RB, Parker C, Miller MC, Tissing H, Doyle GV, Terstappen LW, Pienta KJ, Raghavan D. de Bono JS, et al. Clin Cancer Res. 2008 Oct 1;14(19):6302-9. doi: 10.1158/1078-0432.CCR-08-0872. Clin Cancer Res. 2008. PMID: 18829513

References

1. N Engl J Med. 2004 Aug 19;351(8):781-91 - PubMed
1. J Clin Oncol. 2005 Mar 1;23(7):1420-30 - PubMed
1. J Clin Oncol. 2008 Jul 1;26(19):3213-21 - PubMed

Publication types

Actions